GlaxoSmithKline pens $120M upfront synthetic lethality cancer pact with Fierce 15 winner Ideaya With hard cash from U.K., Imperial to kick-start next-gen COVID-19 vaccine trials this month Nominations for Fierce Biotech's 2020 Fierce 15 Sponsored: The Future of Clinical Research: Digitally Transforming What’s Possible Inventiva’s NASH hopeful cuts inflammation, scarring in phase 2 ETheRNA nabs €34M for mRNA vaccines—including COVID-19 candidate Ona raises €30M to treat metastases by blocking fat intake FDA clears its first prescription video game treatment for ADHD Trial disruption easing, but fallout will linger: report China's Sinopharm touts 100% antibody response for COVID-19 vaccine it's already giving to workers Featured Story | Tuesday, June 16, 2020 As GlaxoSmithKline looks to deepen its cancer R&D, it's penned an oncology development program with Ideaya Biosciences. read more |
| |
|---|
|
Top Stories Tuesday, June 16, 2020 As the U.S., Germany and France start funneling more cash into their life sciences for a solution to the COVID-19 problem, the U.K. is following suit with a new type of vaccine. read more Tuesday, June 16, 2020 So many people see innovation as a given: It happens in the background, takes a good few years and usually comes together with more than a little luck. We don’t see the toil and failure, we see and demand just the final result. If I feel ill, I go to the doctor and ask for medicine, and, most of the time, that will just be there to make me well. read more Monday, June 15, 2020 Sponsors are transforming and future-proofing their clinical research by incorporating virtual options in study protocols. Discover why patients are key to the success of these digital strategies. read more Tuesday, June 16, 2020 Inventiva’s NASH prospect beat placebo at cutting liver inflammation in patients with NASH without making their scarring worse, hitting its primary endpoint in a phase 2b study. The data offer hope for a class of drugs that has been dogged with failure and could set Inventiva’s drug up for accelerated approvals. read more Monday, June 15, 2020 Belgium’s eTheRNA picked up €34 million ($38 million) to bankroll the development of its mRNA technologies as well as a suite of mRNA immunotherapies for cancer and infectious diseases, including a program against SARS-CoV-2, the virus that causes COVID-19. read more Tuesday, June 16, 2020 Ona Therapeutics has raised a €30 million ($34 million) series A round to take biologics that treat metastatic cancer into clinical trials. The R&D plan is underpinned by early evidence that antibodies can stop metastasis-initiating cells from supporting the spread of tumors around the body. read more Monday, June 15, 2020 The FDA has cleared its first video game for children with attention deficit hyperactivity disorder, allowing Akili Interactive’s EndeavorRx to be prescribed as a digital therapeutic. read more Tuesday, June 16, 2020 As CROs and biopharmas adapt to virtual trials and conducting tests amid a pandemic, some studies are back up and running, but future approvals will be hit by last quarter’s chaos. read more Tuesday, June 16, 2020 China's state-run Sinopharm said one of its inactivated COVID-19 vaccines triggered a strong neutralizing antibody response in a phase 1/2 study. And even as the design of a phase 3 trial is still under wraps, the company is reportedly offering the experimental vaccine to employees at state-owned companies who intend to travel overseas. read more Enrollment Showcase | Sponsored by: University of Florida College of Pharmacy Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program. |
| |
|---|
|
Resources Sponsored by: Cenduit Download this case study to read how Cenduit helped one client successfully navigate mid-study changes to medication management. Sponsored by: Research Solutions Learn four ways to squeeze more value from your limited R&D resources. Sponsored by: BioAnalytix Download this eBook and Learn the Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies Sponsored by: Catalent In a series of innovation sessions, Catalent RP Scherer softgel capsules were quickly identified as the ideal solution to drive incremental growth. Learn more. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe. Sponsored by: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored by: Clinical Ink Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19. Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Presented by: ICON Clinical Research Download this whitepaper to learn more about the success factors that are required to keep a pandemic respiratory vaccine trial running at optimal speed and efficiency. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Clarify Health Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Sponsored by: Outer Edge Technology Businesses must maintain pre-pandemic levels of productivity with smaller IT budgets. Learn why an effective Cloud Strategy is imperative for success in these unprecedented times. Medical Affairs Strategic Summit (MASS) East April 14-16, 2020 | New Brunswick, NJ PEGS Virtual Interactive Summit Virtual Event | June 2-26, 2020 European Healthcare Compliance Certificate Program June 2-5, 2020 | Paris, France Drug Development Boot Camp® 2020 November 18-19, 2020 | Register now! Pre-Boot Camp training is in session. | Take your new medicine development skills to the next level. | 